First COVID patient reported in NCR: Woman tests positive in Noida

Noida (Uttar Pradesh) [India], May 24 (ANI): A 55-year-old woman from the National Capital Region has been tested positive for COVID-19, marking the first case in Uttar Pradesh's Noida amid the recent surge in cases in India, as per the Chief Medical Officer (CMO) of Gautam Buddha Nagar.
According to the CMO, Narendra Kumar, the woman from Sector 110 in Noida has been placed under home isolation, with her husband and maid, who are part of the household, testing negative for the virus.
He further added that the woman had travelled by train a few days back.
Earlier, AIIMS Rishikesh had reported three COVID cases, adding to the recent surge in cases across the country. Speaking with ANI, Rishikesh AIIMS Director Meenu Singh informed that one of the three patients has already been discharged.
'Three COVID patients have been reported in the AIIMS... One has been discharged... Another patient is one of our residents. She has been kept in isolation. Another patient is from Gujarat who came here for the Badrinath Yatra,' Dr Meenu Singh said.
Dr Singh also mentioned that this variant of COVID is not very harmful, but people should be cautious.
'The state has kept us on alert. We have implemented COVID-appropriate behaviour in our institute... This variant is not very harmful, but if someone has any comorbidities... then they should get themselves checked,' she said.
Meanwhile, in view of the recent surge in COVID-19 cases in various parts of the country, the Delhi government has issued an advisory directing all hospitals to ensure preparedness for the availability of beds, oxygen, medicines, and vaccines.
However, according to the experts, the situation is under control.
Dr Suranjit Chatterjee, Senior Consultant in Internal Medicine at Indraprastha Apollo Hospital, said on Friday, 'At the moment, the situation is under control. There are, at most, sporadic cases, which are also rare. Even the present cases are being managed very easily.'
'They are not being hospitalised. This is what we were expecting: that when COVID happened, it would remain a seasonal flu which could be treated very easily. The situation is not one of panic...' he further said.
'We haven't seen any hospitalised or ICU Covid-19 cases in the hospital. Only hype has been created, but there is no need to panic,' he said.
As of May 19, the number of active COVID-19 cases in India stands at 257 - a very low figure considering the country's large population. Almost all of these cases are mild, with no hospitalisation required. The government also has a robust system for surveillance of respiratory viral illnesses, including COVID-19, through the Integrated Disease Surveillance Programme (IDSP) and the ICMR. (ANI)

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Mint

2 hours ago

• Mint

India€™s biotech sector grew nearly fivefold in past decade: DBT Secretary

New Delhi, Jun 23 (PTI) India's biotechnology sector has expanded rapidly in the past decade, with its bioeconomy growing from USD 35.5 billion in 2014 to USD 165.7 billion in 2024, according to Rajesh S Gokhale, Secretary, Department of Biotechnology (DBT). He said the sector is now aiming for a USD 300 billion target by 2030, as scientific advances begin to translate into industrial and public health gains. "Biotechnology is no longer a fringe discipline, it's now a strategic driver for India's economic and health priorities," Gokhale said at a press conference highlighting 11 years of DBT's achievements. Among the standout initiatives is GenomeIndia, a nationwide effort to sequence the genomes of 10,000 individuals from 99 population groups, he said. The data, released earlier this year, is expected to inform personalised medicine and help researchers develop diagnostics tailored to Indian populations. Gokhale also highlighted India's first in-human gene therapy trial using a lentiviral vector for Severe Hemophilia A. India's vaccine response, Gokhale said, demonstrated the capacity of the DBT-backed innovation ecosystem. Under "Mission COVID Suraksha", five COVID-19 vaccines developed with DBT support received emergency approvals, including GEMCOVAC-19, the world's first thermostable mRNA vaccine. Other products include the intranasal COVID-19 vaccine and CERVAVAC, India's first indigenous quadrivalent HPV vaccine, now part of the National Immunization Programme, according to document shared at the briefing. Indian scientists contributed to decoding the complex genome of bread wheat, a global staple crop, and published a reference genome with 94 per cent coverage. Other research showed how Mycobacterium tuberculosis can infect liver cells and undermine TB treatment efficacy, while a study on taurine levels suggested amino acid may influence aging. Gokhale said India's biotech startup landscape has changed dramatically, with over 10,000 startups now in the sector, up from a few hundred a decade ago. Over 800 biotech products have emerged in this period. Through BIRAC, DBT has helped set up 95 bio-incubators across 21 states. Infrastructure investments include India's first dedicated biomanufacturing institute in Mohali and vaccine testing labs notified as Central Drug Laboratories. Speed breeding facilities have also been established to accelerate the development of climate-resilient crops. The BioE3 policy, approved by the Cabinet in 2024, is aimed at fostering high-performance biomanufacturing aligned with Net Zero targets.

Hindustan Times

2 hours ago

• Hindustan Times

378 healthcare professionals to be deployed for Puri Rath Yatra: Minister

Bhubaneswar, In preparation for the upcoming Rath Yatra, the Odisha government has announced a series of health measures, including the deployment of 378 healthcare professionals and 265 hospital beds to ensure public safety during the annual religious event in Puri. 378 healthcare professionals to be deployed for Puri Rath Yatra: Minister Talking to reporters, Health and Family Welfare Minister Mukesh Mahaling said elaborate arrangements have been made to handle medical emergencies during the festival, which draws lakhs of devotees each year. Mahaling added that in addition to 378 doctors and para-medical staff, 69 first-aid centres and 74 ambulances will be kept ready for any emergencies. Given the recent outbreak of diarrhoea, the government has taken precautions to ensure the availability of safe drinking water and prevent the sale of stale food in the town. The additional 265 hospital beds include 15 ICU beds and 100 beds at the ANM Training Centre, while the Puri District Headquarters Hospital has reserved 68 beds, including general, burn, and ICU facilities. "I hope that the Rath Yatra will be conducted smoothly with the blessings of Lord Jagannath," the minister said. The District Headquarters Hospital has reserved 68 beds, including 50 general beds, 8 burn ward beds, and 10 ICU beds, an official statement of health department said. Additionally, 200 units of blood have been reserved while two minor operation theatres along with specialised dressing rooms have been set up to handle any medical emergencies, it said. For the first time, a team of doctors from AIIMS Bhubaneswar will be stationed at medical centres in Puri to provide additional support. Similarly, a specialised 10-bed air-conditioned heat stroke centre has been established at Talabania to address weather-related health issues. "Rigorous health monitoring and disease prevention measures are in place to maintain public health standards throughout the Ratha Yatra period," the statement further said. To curb outbreak of any water or food-borne disease, a total of eight food safety officers have been assigned. All 108 emergency ambulances will remain on high alert and operate along designated corridors with the support of NGO volunteers. To prevent disease outbreaks, eight food safety officers and three mobile surveillance teams have been deployed. So far, 494 kg of unhygienic food has been destroyed after 249 inspections of food establishments. The administration has also collected 84 food samples, 22 water samples, and conducted 10 stool culture tests and 82 water analyses. An extensive information, education, and communication campaign will be undertaken to promote public health awareness covering food safety, safe drinking water practices, hand washing and hygiene protocols, ORS usage, health programs, COVID-19 prevention measures, and Ayushman Bharat Program awareness, the statement said. A dedicated Ratha Yatra control room will operate round-the-clock throughout the festival period to coordinate all health-related activities and respond to emergencies. The control room can be reached at mobile number 91 6370560247 and landline number 06752-222175 for any medical assistance or information. This article was generated from an automated news agency feed without modifications to text.

Economic Times

7 hours ago

• Economic Times

Amazon, not the first, nor the last to attempt disruption. 5 diagnostics stocks: From downside forecast, to upside as high as 67%

Just a couple of weeks back, there were headlines about rising Covid cases in Southeast Asian countries. And alarm bells started ringing in India. Almost in step with this development, a domestic diagnostic stock again came into the limelight, with some reports mentioning how the company is getting ready for another surge in Covid. Fortunately, there was no surge of cases in India. And there certainly was no panic. So, it is probably good that FONT SIZE SAVE PRINT COMMENT